Share Prices & Company Research

Market News

16 Mar 2021 | 07:49

AstraZeneca increases Covid-19 vaccine doses to US

(Sharecast News) - AstraZeneca said it had amended its existing agreement with the US government to supply up to 500,000 extra doses of its Covid-19 vaccine AZD7442 for $205m. The agreement with the Department of Health and Human Services and the Department of Defense (DoD) builds on an agreement from October 2020 for the support of the late-stage development of AZD7442 and for the supply of an initial 100,000 doses of the LAAB combination, the company said on Tuesday.

Astra has a separate agreement to supply the DoD with 100,000 doses, bringing potential US supplies of AZD7442 to 700,000 in 2021.

The drug currently being evaluated for the prevention and treatment of Covid-19 in late-stage trials in more than 9,000 participants around the world.

In a separate statement, the company said it had completed the sale of its 26.7% stake in Viela Bio, Inc. The sale came as Horizon Therapeutics has proposed to acquire Viela.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.